Refractory Chronic Lymphocytic Leukemia

Showing NaN - NaN of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +15 more
  • Anti-CD19/CD20/CD22 CAR T-Cells
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 4, 2022

Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

Recruiting
  • Relapsed Non Hodgkin Lymphoma
  • +6 more
  • Cincinnati, Ohio
  • +4 more
Aug 3, 2022

Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt

Active, not recruiting
  • Prolymphocytic Leukemia
  • +4 more
  • Columbus, Ohio
  • +1 more
Apr 29, 2022

Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

Active, not recruiting
  • Contiguous Stage II Small Lymphocytic Lymphoma
  • +11 more
  • MOR00208
  • +2 more
  • Columbus, Ohio
    The Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus (drug, biological, other)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Bcl-2 Inhibitor GDC-0199
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 29, 2021

Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,

Completed
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2018

Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +41 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 22, 2017

Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in United

Completed
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Akt Inhibitor MK2206
  • +3 more
  • Scottsdale, Arizona
  • +43 more
Aug 17, 2017

B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 2, 2017

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Aug 31, 2016

B-cell Chronic Lymphocytic Leukemia, Hematopoietic/Lymphoid Cancer, Prolymphocytic Leukemia Trial in Columbus (carfilzomib,

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +4 more
  • Columbus, Ohio
    Ohio State University Medical Center
May 6, 2016

Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,

Terminated
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Alvocidib Hydrochloride
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 10, 2015

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • alvespimycin hydrochloride
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Nov 3, 2015

Anemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia Trial in Columbus (Alvocidib Hydrochloride, Lenalidomide,

Completed
  • Anemia
  • +5 more
  • Alvocidib Hydrochloride
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 1, 2015

Noncontiguous Stage II Small Lymphocytic Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia

Completed
  • Noncontiguous Stage II Small Lymphocytic Lymphoma
  • +4 more
  • apolizumab
  • +2 more
  • La Jolla, California
  • +1 more
Jul 15, 2013

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Columbus

Terminated
  • Adult Acute Basophilic Leukemia
  • +34 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

MALT, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma Trial in Columbus (apolizumab,

Completed
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +13 more
  • apolizumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +42 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013